59 results
424B5
WINT
Windtree Therapeutics Inc
9 Nov 23
Prospectus supplement for primary offering
4:11pm
, we initiated a Phase 2 global clinical study, or the SEISMiC Study, to evaluate istaroxime for the treatment of early cardiogenic shock (Society … at the European Society of Cardiology Heart Failure Meeting in Madrid, Spain and, in September 2022, the results were published in the European
424B4
e6r3x q6d63n1a
20 Apr 23
Prospectus supplement with pricing info
6:03pm
8-K
EX-99.1
jn2wp3j
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
wypogwflfxtb3u233
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
8-K
EX-99.1
h5y4idx1p4x7dnems
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
yx71un
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm